Advanced Molecular Solutions

VLS Retatrutide 20mg

VLS Retatrutide 20mg represents the most advanced weight management science available today. As the world's first triple hormone receptor agonist — targeting GIP, GLP-1, and glucagon simultaneously — it delivers a depth of metabolic action that no single or dual-agonist compound can match. With clinical trials recording up to 28.7% mean body weight reduction over 68 weeks, the highest figure ever published in a Phase 3 obesity trial, retatrutide sets a new benchmark in evidence-based weight loss. Whether your goal is significant fat reduction, improved metabolic health, or long-term body composition change, VLS Retatrutide 20mg offers a scientifically validated, precisely dosed, and QR-verified solution — supplied authentically from the UK and backed by the most compelling clinical data in the field.

VLS Retatrutide 20m

VLS Retatrutide 40mg

VLS Retatrutide 40mg delivers the same groundbreaking triple-receptor science as the 20mg formulation — with greater peptide reserve for those requiring extended protocols or higher cumulative doses. Built on the same LY3437943 compound that achieved 28.7% mean body weight reduction in Phase 3 trials, the 40mg pen is designed for individuals who are further along in their journey and require a higher-capacity cartridge without interruption to their protocol. It carries the full weight of retatrutide's clinical evidence — including benefits across obesity, liver health, metabolic markers, and emerging indications — in a single, convenient, prefilled pen. For those serious about results, VLS Retatrutide 40mg is the most powerful tool in our range, authenticated by QR verification and shipped directly from the UK

VLS Retatrutide 40mg

VLS Tirzepatide 20mg

VLS Tirzepatide 20mg stands as the most clinically proven dual-action weight management compound on the market today. In the first ever head-to-head Phase 3 comparison against semaglutide — published in the New England Journal of Medicine — tirzepatide achieved 47% greater relative weight loss, demonstrating its clear superiority over the previous gold standard. With FDA and EMA approval, a well-established safety profile, and real-world data showing over 95% of patients achieving meaningful weight reduction, tirzepatide offers both the scientific rigour and the practical reliability that patients and healthcare professionals demand. VLS Tirzepatide 20mg brings this proven dual GIP and GLP-1 science to you in a precise, flexible prefilled pen — QR-verified authentic and shipped directly from the UK.

VLS Tirzepatide 20mg

VLS Semaglutide 5mg

VLS Semaglutide 5mg is where the GLP-1 revolution began — and it remains one of the most trusted and widely used weight management compounds in the world. With over a decade of clinical data, approval in more than 50 countries, and a cardiovascular outcomes trial proving a 20% reduction in major cardiac events, semaglutide offers a level of safety evidence and long-term confidence that no newer compound can yet match. For individuals beginning their weight management journey, or those who prefer a well-characterised and gently titrated protocol, VLS Semaglutide 5mg provides a proven, accessible, and scientifically sound starting point. Precise low-dose titration, a prefilled ready-to-use pen, and full QR verification make it as practical as it is powerful — authentic, trusted, and delivered from the UK.

VLS Semaglutide 5mg

Research Inquiry & Order Request